AAAP BUPRENORPHINE TRAINING SESSIONS

NEW USERS & RETURNING USERS CLICK HERE

  (Users who have previously registered to take the web-based or cd-rom courses.)

___________________________________________________________________

JUST RELEASED!!! 

The "Half and Half" Course 

for Buprenorphine Training

In an effort to provide training in a way that is most flexible for the practicing physician AAAP has just created the "Half and Half" course.

The first “half” of the course consists of participants taking 3.75 hours of CD-ROM training containing five modules from the AAAP on-line buprenorphine course. The second “half” of the course is a 4.25 hour face-to-face classroom-style training in a small group setting with a course director* who has already obtained the waiver to practice with buprenorphine and is doing so in his/her community.  The combined online and face-to-face training provides the 8 hours needed to obtain the waiver to use buprenorphine in office-based treatment of opioid dependence.

Click HERE for more information on the "Half and Half" Course

___________________________________________________________________

Buprenorphine and Office-Based Treatment 

of Opioid Dependence

SAMHSA Buprenorphine Info    

Buprenorphine Physician Locator

Other Organizations' Buprenorphine Trainings

BACKGROUND

    The "Drug Addiction Treatment Act of 2000" creates the long-awaited opportunity to expand treatment for opiate dependence into the mainstream of medical practice, increase the number of persons treated and have an important positive public health impact.  

    The legislation specifies several ways in which physicians can be considered "qualified" to prescribe and dispense buprenorphine in their offices for the treatment of opioid dependence. Some will need to complete training prior to notifying the U.S. Department of Health and Human Services (DHHS) of their intention to begin prescribing buprenorphine for the treatment of opioid dependence. Others, such as those certified in Addiction Medicine or Addiction Psychiatry or those who participated in clinical trials, are not required to complete any further training. However, it is likely that many physicians who are defined as qualified, by virtue of their subspecialty certification or specific experience, will elect to take part in an educational program to review the many elements involved in implementing this new treatment modality in a setting where pharmacological management of opioid dependence has not been provided before.

ABOUT THE TRAINING

    AAAP is one of five organizations designated by the U.S. Department of Health and Human Services (DHHS) to provide such training for physicians to dispense buprenorphine in office practice for treatment of opioid dependence. AAAP Buprenorphine Training Sessions meet the eight hour requirement.

    Participation in training will provide physicians with a comprehensive overview of buprenorphine prescribing and its safe and effective use in an office-based setting.

    This training is designed for physicians who are likely to treat opiate-dependent persons in their practice, such as those in family practice, general internal medicine, psychiatry, pediatrics and adolescent medicine specialists. 

This training would be most valuable for:

• Physicians and other primary care providers who are not addiction specialists who would like to provide treatment for opiate-addicted patients.

• Addiction specialists who provide treatment for opiate addiction and who want to increase treatment options.

• Addiction specialists who have not treated opiate addiction in their practices, but who want to learn how to do so.

WHEN & WHERE

    Training will be offered through national meetings, regional workshops and the Internet. Scheduled sessions will be posted on this website.  For more information, contact AAAP